Senior Director
AstraZeneca
Dr. Niresh Hariparsad is a Senior Director and currently functions as the Site Head of DMPK for Oncology R&D at AstraZeneca, based in Boston, MA. Prior to joining AstraZeneca, Niresh held various leadership roles at Merck and Vertex Pharmaceuticals where he was involved in DMPK support of projects from target identification through to various stages of clinical development. Niresh is currently the DMPK project lead for Camizestrant (an oral SERD) and has contributed to the discovery and development of compounds in several disease areas including multiple sclerosis, focal segmental glomerular sclerosis, hepatitis-C and cystic fibrosis . Niresh has functioned as the past Chair of the IQ TALG Induction Working Group (WG) and now functions as the Co-Chair of the PBPK Modeling for Induction WG as well as the Chair of the Quantitative Fractional Metabolism WG. He has also been involved in various cross industry initiatives related to drug transporters and novel tools for ADME. Niresh is actively involved in speaking engagements at national and international scientific meetings and has published over 20 peer reviewed research articles. Niresh’s research interests include the use of novel approaches to enhance the prediction of human PK and drug-drug interaction risk for compounds advancing to the clinic.
Disclosure information not submitted.
Monday, April 25, 2022
8:00 AM – 1:30 PM ET
.png)